Medline Sponsors Raise $2.3 Billion in Secondary Share Sale
What happened
Medline backers raised approximately US$2.3 billion through a marketed follow-on offering and concurrent share repurchase. The all-secondary sale involved 60 million shares priced at US$35.50 each. Blackstone, The Carlyle Group, Hellman & Friedman, Singapore sovereign wealth fund GIC, and Abu Dhabi Investment Authority reduced their stake in Medline to 39.6% from 45.5%.
From ifre.com
Why it matters
The transaction marks the third sponsor selldown since Medline went public in December 2025. Including this recent sale, the sponsors have generated more than US$8 billion since the IPO.
From ifre.com
Who's involved
- Carlyle GroupPrincipal backer that reduced its stake in Medline
- BlackstonePrincipal backer that reduced its stake in Medline
- Abu Dhabi Investment AuthoritySponsor that reduced its stake in Medline
- Goldman SachsJoint global coordinator of the secondary share sale
- Morgan StanleyJoint global coordinator of the secondary share sale
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Abu Dhabi Investment AuthoritySpeculative
Abu Dhabi Investment Authority could realize profits from the sale, increasing investment returns.
- BlackstoneSpeculative
Blackstone might adjust its capital allocation strategy following the monetization effort.
- Carlyle GroupSpeculative
The Carlyle Group may generate increased revenue from the sale of its Medline stake.
Keep exploring
The entities involved
-
Carlyle Group
American alternative asset management company
Nothing else this week.
-
Blackstone
town in Worcester County, Massachusetts, United States
Nothing else this week.